Article
Recurrent Epidermal Growth Factor Receptor 2 (ERBB2) Mutations Drive the Pathogenesis of Multifocal Neurofibroma Variants.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc - 1 May 2026
Yeung Maximus C F, Lefkowitz Robert A, Antonescu Cristina R
Abstract excerpt
Recurrent Epidermal Growth Factor Receptor 2 (ERBB2) mutations have been recently documented in a small group of hybrid neurofibroma/schwannoma peripheral nerve sheath tumors (PNST) in patients with presumed sporadic schwannomatosis. Prompted by 2 cases of plexiform neurofibromas harboring ERBB2 hotspot mutations, but lacking germline alterations, we sought to investigate the clinicopathologic features of PNST...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
